Current Treatment Options in Neurology

Papers
(The median citation count of Current Treatment Options in Neurology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Genetic Testing for Epilepsy: A User Guide46
Education and Team Science in Neurocritical Care44
Treatment of Symptomatic Carotid Webs: Current Evidence and Future Directions29
Continuous EEG in Day to Day Neurocritical Care – A Case Based Review28
Reducing Sudden Unexpected Death in Epilepsy: Considering Risk Factors, Pathophysiology and Strategies27
Tau in Multiple Sclerosis: A Review of Therapeutic Potential23
Updates in the Management of Neuromuscular Emergencies20
Should we Treat Sleep Apnoea to Prevent Dementia?18
Treatment of Vascular Myelopathies11
Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials11
Speech Language Pathology in the Neurocritical Care Unit11
Addressing the Burden of Pathological Fatigue in Stroke Survivors: A Review of Present and Potential Non-Pharmacological and Pharmacotherapeutic Options9
Correction to: Diagnosis and Management of Progressive Corticobasal Syndrome9
Treatment of Malignant Cerebral Edema in Acute Ischemic Stroke9
Ocular Myasthenia Gravis7
Biomarker Defined Acute Optic Neuritis: A Review and Perspective7
Correction to: Gut Microbiome as Potential Therapeutics in Multiple Sclerosis6
Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?5
Treatment of Fever in Neurologically Critically Ill Patients5
Epilepsy Management in Transgender and Gender Diverse People5
Managing the Behavioral and Psychological Symptoms of Dementia5
Updates in the Management of Cervical Artery Dissections5
Management Strategies for Atypical Parkinsonism4
Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)4
Predicting and Treating Post-traumatic Epilepsy4
The A2F ICU Liberation Bundle in Neurocritical Care4
Headache as a Neurologic Manifestation of Systemic Disease4
Clinical Trial Outcome Measurements in Lennox-Gastaut Syndrome and Their Application to the Development of Targeted Treatments4
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome3
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy3
Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder3
Seizures in the Setting of COVID-193
Dual Antiplatelet Therapy in Ischemic Stroke Prevention: Which Two Could Be Better than One?3
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations3
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease3
Treatment Approaches in Pediatric Relapsing Autoimmune Encephalitis3
Approach to the Management of Sodium Disorders in the Neuro Critical Care Unit3
Mechanical Thrombectomy for Acute Ischemic Stroke: Current State and Future Directions3
Clinical Applications of Non-Invasive Brain Stimulation in Stroke Recovery: A Review of Current Evidence and Therapeutic Strategies3
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults3
Correction to: Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?3
Update on Treatment of Idiopathic (and Non-Idiopathic) Orbital Inflammation3
Update on Paraneoplastic Neuromuscular Disorders2
Current Endovascular Treatments in Neuro-Ophthalmology2
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview2
Update on Transient Global Amnesia (TGA): Current Theories Underlying the Etiology, Diagnosis, Prognosis, and Management of TGA2
Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications2
Evaluation and Management of Delirium in Dementia2
Current Treatment Options for Patients with Myotonic Dystrophy Type 22
The Efficacy of Deep Brain Stimulation in the Treatment of Essential Tremor: A Systematic Review2
Surgical Management of Spontaneous Intracerebral Hemorrhage2
Treatment of Persistent Postural-Perceptual Dizziness (PPPD)2
Epilepsy as a Wilding of Sleep2
Shared Decision-Making and Family Meetings in Neurocritical Care2
Updated Review of Leber Hereditary Optic Neuropathy2
Telestroke’s Role Through the COVID-19 Pandemic and Beyond2
Distinguishing Benign Rashes From Severe Skin Reactions From Anti-Seizure Medications2
Ethical Considerations in the Treatment of Cerebrovascular Disease2
Correction to: Diagnosis and Management of Posterior Cortical Atrophy2
Delving Into the Significance of Brain’s Collateral Circulation in the Era of Revascularization Therapy2
Progressive Supranuclear Palsy Diagnosis and Treatment1
Parkinson Disease Dementia Management: an Update of Current Evidence and Future Directions1
Diagnosis and Management of Progressive Corticobasal Syndrome1
The Efficiency of Established Diagnostic and Therapeutic Approaches in the Treatment of Trigeminal Neuralgia1
The Knowns and Unknowns of Prion Protein in Immune Modulation and the Pathogenesis of Neuroautoimmune Diseases1
Toxic Myopathies1
Treatment of Intracerebral Vascular Malformations: When to Intervene1
The Impact of Epstein-Barr Virus on Autoimmune Neuromuscular Disorders: A Comparative Study of Myasthenia Gravis and Guillain–Barre Syndrome1
Advances in the Pharmacological Management of Parkinson’s Disease1
Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)1
The Role of Rehabilitation in Neurological Critical Care: Innovations in Early Mobilization1
The Impacts of the Covid-19 Pandemic on Cerebral Infarction Treatment: Challenges and Opportunities1
Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas1
Update on Simulation in Neurocritical Care – Current Applications and Future Directions1
A Review of the Current Literature and Updates on Embolic Stroke of Undetermined Source (ESUS)1
Drug Combination to Slow Down the Progression of Amyotrophic Lateral Sclerosis1
Sleep Disorders in Adults with Intellectual Disability: Current Status and Future Directions1
Correction to: Speech Language Pathology in the Neurocritical Care Unit1
Inhibiting CD40 Ligand in Multiple Sclerosis: A Review of Emerging Therapeutic Potential1
Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review1
Management of External Ventricular Drains and Related Complications: a Narrative Review1
A New Era in the Treatment of Myasthenia Gravis: Six New Medications in The Last 6 Years1
0.048895835876465